Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

Ratios

vs
industry
vs
history
PE Ratio 22.41
IYH's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 22.41 )
Ranked among companies with meaningful PE Ratio only.
IYH' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 22.41
0
24.27
PE Ratio without NRI 22.41
IYH's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 22.41 )
Ranked among companies with meaningful PE Ratio without NRI only.
IYH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.27
Current: 22.41
0
24.27
PB Ratio 3.66
IYH's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 3.66 )
Ranked among companies with meaningful PB Ratio only.
IYH' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.95
Current: 3.66
0
3.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.03
IYH's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.03 )
Ranked among companies with meaningful Dividend Yield % only.
IYH' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.03
0
2.3
5-Year Yield-on-Cost % 2.03
IYH's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. IYH: 2.03 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
IYH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.3
Current: 2.03
0
2.3

More Statistics

Short Percentage of Float0.00%
52-Week Range $137.39 - 160.18
Shares Outstanding (Mil)12,000,000.00
» More Articles for IYH

Headlines

Articles On GuruFocus.com
15 Questions With Sid Lembirik, Managing Partner at Lembirik Group Investments Mar 25 2017 
21 Questions With Jason Rivera of Rivera Holdings Mar 25 2017 
Stocks Reach Their 3-Year Lows Mar 25 2017 
Weekly Top Insider Buys Highlight for the Week of March 24 Mar 25 2017 
Harmony Gold's Strike Ends Mar 24 2017 
Abbott Sells More Mylan Holdings Mar 24 2017 
Chou Income Fund 4th Quarter Message to Shareholders Mar 24 2017 
Francis Chou Comments on Resolute Forest Products Mar 24 2017 
Francis Chou Comments on Sears Holdings Corp Mar 24 2017 
Francis Chou Comments on Valeant Mar 24 2017 

More From Other Websites
Healthcare Stocks Await TrumpCare Vote Mar 23 2017
A Look at Ionis Pharmaceuticals’ Spinraza Mar 22 2017
Trump, Biogen and Amgen Hammer Healthcare ETFs Mar 20 2017
How BMY’s Neuroscience, Immunoscience Segments Performed in 2016 Mar 20 2017
Pfizer’s Cash Flow Stamina versus Merck’s Ambitious R&D Mar 15 2017
Johnson & Johnson’s Medical Devices Segment Mar 14 2017
Trump finally builds a wall — though it’s not along the Mexican border Mar 09 2017
GOP Health Plan: Winners, Losers & Who Knows Mar 09 2017
Will Obamacare Repeal Make Healthcare Stocks Sick? Mar 07 2017
Analyzing Pfizer’s Estimates for the Future Mar 01 2017
Understanding Incyte’s Revenue Stream for 2016 Feb 28 2017
Eli Lilly & Co.’s Revenues in 4Q16 Feb 23 2017
How to Play Pfizer's Fourth-Quarter Results With ETFs Feb 01 2017
Why GE’s Healthcare Revenues Rose in 4Q16 Jan 27 2017
Analyzing Bristol-Myers Squibb’s Other Segments in 4Q16 Jan 25 2017
How Should Investors Play Healthcare? Jan 24 2017
3 ETFs to Buy If You're Impressed With Johnson & Johnson's Fourth Quarter Jan 24 2017
Why health-care stocks aren’t moving after President Trump’s Obamacare executive order Jan 24 2017
U.S. fund managers betting Trump fails to rewrite Obamacare Jan 24 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK